JPMORGAN CHASE & CO - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 37 filers reported holding RANI THERAPEUTICS HLDGS INC in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2023$9,655
-64.1%
4,439
-32.0%
0.00%
Q2 2023$26,883
+284.0%
6,525
+352.2%
0.00%
Q1 2023$7,000
+139900.0%
1,443
+82.9%
0.00%
Q4 2022$5
-100.0%
789
-43.5%
0.00%
Q3 2022$13,000
+8.3%
1,397
+17.6%
0.00%
Q2 2022$12,000
-61.3%
1,188
-49.0%
0.00%
Q1 2022$31,000
-54.4%
2,329
-44.4%
0.00%
Q4 2021$68,0004,1860.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$1,073,5450.87%
Alpha Square Group S LLC 86,946$189,1080.19%
LASRY MARC 62,887$136,7790.14%
Alphabet Inc. 448,492$973,2270.06%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$1,034,7950.03%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$20,9040.02%
Activest Wealth Management 9,800$21,3150.01%
Lafayette Investments 19,893$43,2680.01%
MOTCO 48,129$104,6810.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 51,500$112,0130.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders